Disc Medicine (IRON) is back in focus after the FDA issued a Complete Response Letter for its lead EPP drug, bitopertin, asking for additional Phase 3 data and delaying the potential approval timeline ...
In most instances, getting more horsepower from your engine requires "leaning" on it with non-stock performance modifications. Higher compression ratios and bigger-lift camshafts produce increased ...
Disc Medicine Inc. Annual cash flow by MarketWatch. View IRON net cash flow, operating cash flow, operating expenses and cash dividends.